Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Heal...
Saved in:
| HerausgeberIn: | |
|---|---|
| Sonstige: | |
| Year of Publication: | 2020 |
| Language: | English |
| Physical Description: | 1 electronic resource (128 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993545803504498 |
|---|---|
| ctrlnum |
(CKB)5400000000041128 (oapen)https://directory.doabooks.org/handle/20.500.12854/69153 (EXLCZ)995400000000041128 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Ferraris, Davide Maria edt Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (128 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Health Organization (WHO), TB is considered the ninth cause of death worldwide and the leading cause of mortality by a single infectious agent, with the highest rate of infections and death toll rate mostly concentrated in developing and low-income countries. We present here the editorial section to the Special Issue entitled “Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment” that includes 7 research articles and a review. The scientific contributions included in the Special Issue mainly focus on the characterization of MTB strains emerging in TB endemic countries as well as on multiple mechanisms adopted by the bacteria to resist and to adapt to antitubercular therapies. English Research & information: general bicssc Biology, life sciences bicssc Mycobacterium tuberculosis line probe assay second-line drugs drug resistance XDR-TB MDR-TB omics analysis TB treatment system analysis Beijing B0/W148 Mycobacterium smegmatis imidazo[1,2-b][1,2,4,5]tetrazine MmpS5-MmpL5 efflux drug discovery tuberculosis immune activation HLA-DR CD38 treatment response Mycobacterium macrophage apoptosis effector cytokine microRNA Beijing genotype Central Asia Outbreak murine infection model Virulence pre-XDR-TB Mycobacterium avium unique metabolic pathways subtractive genomics drug target uncharacterized proteins BM-MSCs Mtb bone-homing stem cell niche latent tuberculosis relapse liposomes M. tuberculosis host-pathogen interactions immune response antitubercular drug discovery antitubercular treatments IL-18 IL-18BP IL-18R gene expression 3-03936-658-0 3-03936-659-9 Miggiano, Riccardo edt Rizzi, Menico edt Ferraris, Davide Maria oth Miggiano, Riccardo oth Rizzi, Menico oth |
| language |
English |
| format |
eBook |
| author2 |
Miggiano, Riccardo Rizzi, Menico Ferraris, Davide Maria Miggiano, Riccardo Rizzi, Menico |
| author_facet |
Miggiano, Riccardo Rizzi, Menico Ferraris, Davide Maria Miggiano, Riccardo Rizzi, Menico |
| author2_variant |
d m f dm dmf r m rm m r mr |
| author2_role |
HerausgeberIn HerausgeberIn Sonstige Sonstige Sonstige |
| title |
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment |
| spellingShingle |
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment |
| title_full |
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment |
| title_fullStr |
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment |
| title_full_unstemmed |
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment |
| title_auth |
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment |
| title_new |
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment |
| title_sort |
mycobacterium tuberculosis pathogenesis, infection prevention and treatment |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2020 |
| physical |
1 electronic resource (128 p.) |
| isbn |
3-03936-658-0 3-03936-659-9 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT ferrarisdavidemaria mycobacteriumtuberculosispathogenesisinfectionpreventionandtreatment AT miggianoriccardo mycobacteriumtuberculosispathogenesisinfectionpreventionandtreatment AT rizzimenico mycobacteriumtuberculosispathogenesisinfectionpreventionandtreatment |
| status_str |
n |
| ids_txt_mv |
(CKB)5400000000041128 (oapen)https://directory.doabooks.org/handle/20.500.12854/69153 (EXLCZ)995400000000041128 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment |
| author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField |
| _version_ |
1796648768406290432 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03790nam-a2200973z--4500</leader><controlfield tag="001">993545803504498</controlfield><controlfield tag="005">20231214133603.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000041128</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69153</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000041128</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ferraris, Davide Maria</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (128 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Health Organization (WHO), TB is considered the ninth cause of death worldwide and the leading cause of mortality by a single infectious agent, with the highest rate of infections and death toll rate mostly concentrated in developing and low-income countries. We present here the editorial section to the Special Issue entitled “Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment” that includes 7 research articles and a review. The scientific contributions included in the Special Issue mainly focus on the characterization of MTB strains emerging in TB endemic countries as well as on multiple mechanisms adopted by the bacteria to resist and to adapt to antitubercular therapies.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Research & information: general</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biology, life sciences</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mycobacterium tuberculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">line probe assay</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">second-line drugs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">XDR-TB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MDR-TB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">omics analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TB treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">system analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Beijing B0/W148</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mycobacterium smegmatis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">imidazo[1,2-b][1,2,4,5]tetrazine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MmpS5-MmpL5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">efflux</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug discovery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tuberculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune activation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HLA-DR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CD38</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">treatment response</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mycobacterium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">macrophage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">apoptosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">effector</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytokine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Beijing genotype</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Central Asia Outbreak</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">murine infection model</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Virulence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pre-XDR-TB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mycobacterium avium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">unique metabolic pathways</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">subtractive genomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug target</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">uncharacterized proteins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BM-MSCs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mtb</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bone-homing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stem cell niche</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">latent tuberculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">relapse</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liposomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">M. tuberculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">host-pathogen interactions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune response</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antitubercular drug discovery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antitubercular treatments</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IL-18</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IL-18BP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IL-18R</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gene expression</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03936-658-0</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03936-659-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miggiano, Riccardo</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rizzi, Menico</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferraris, Davide Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miggiano, Riccardo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rizzi, Menico</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:58:36 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338023610004498&Force_direct=true</subfield><subfield code="Z">5338023610004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338023610004498</subfield></datafield></record></collection> |